Received May 20, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | UNK | — | — |
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 2 | U8372AA | — |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 1 | — | OT |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 2 | 2164395 | OT |
No symptomatic events were reported; the patient's first dose of ROTATEQ was given on 4/22/2026, and patient was provided PENTACEL instead of VAXELIS on 4/22/2026. Medical assistant noted that both VAXELIS and ROTATEQ were administered today (5/19/2026); This Spontaneous report was received from a physician assistant and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 22-Apr-2026, the patient was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), oral solution, administered orally; and with Diphtheria vaccine toxoid (+) HIB vaccine conj (tet tox) (+) Pertussis vaccine acellular 5-component (+) Polio vaccine inact 3v (MRC 5) (+) Tetanus vaccine toxoid (PENTACEL) (total) Asked But Unknown Batch/Lot Number. On 19-May-2026, the patient was vaccinated with the second dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), oral solution, at a dose of 0.50 mL, (Batch/Lot Number: 2164395, Expiration date reported and validated as 22-Mar-2027); and with Diphtheria and Tetanus Toxoids, and Acellular Pertussis, Inactivated Poliovirus, Hib Conjugate (MPC) and rHBV Vaccine (VAXELIS), at a dose of 0.50 mL, (Batch/Lot Number: U8372AA, Expiration date reported and validated as 31-Jan-2028); all vaccines administered as prophylaxis (inappropriate schedule of vaccine administered). No adverse events were reported.